CD19 and Marinesco-Sjogren syndrome: The accumulation of albumin in the BALF, a marker of vascular leakage and diffuse alveolar damage [35], also indicated no alleviation of MSS-induced HP exacerbation in mice with CD19-driven S1P1 deletion (Fig. 3C).